U.S loans $1.1 bln to Ginkgo Bioworks for pandemic effort
The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics. Read More